Boehringer Ingelheim Venture Fund

BIVF invests in groundbreaking biotech firms developing innovative therapeutics in immuno-oncology, regenerative medicine, infectious diseases, and digital health. Focuses on early-stage, high-need areas with novel platforms, vaccines, and biologics. Global reach.

Funding Stage: Pre-Seed / Seed, Series A/B

Investor type: Corporate VC

Investment Areas: Biotechnology, Finance, Venture Capital,

Country: Germany